Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Venous Thromboembolism 11Venous Thrombosis 4Neoplasms 4Thrombosis 3Pulmonary Embolism 3Thrombocytopenia 1Sarcoma 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Bone Neoplasms 1Abdominal Neoplasms 1

Interventions

Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematoma × Enoxaparin × Classical hematology × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡